Hedge funder renews call for Allergan CEO-chairman split, citing 'chronic underperformance'

Last year, Appaloosa and Senator Investment Group wrote to Allergan’s board requesting a series of changes, including a split of the CEO and chairman roles both currently held by Brent Saunders. And they're not happy about being ignored.